MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients

Not Applicable
Completed
Conditions
HIV Infections
Peripheral Nervous System Disease
Interventions
First Posted Date
2001-08-31
Last Posted Date
2021-11-03
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
260
Registration Number
NCT00000817
Locations
🇺🇸

Harlem AIDS Treatment Group / Harlem Hosp Ctr, New York, New York, United States

🇺🇸

Partners Research, Albuquerque, New Mexico, United States

🇺🇸

Clinical Directors Network of Region II, New York, New York, United States

and more 8 locations

Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms

Not Applicable
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-02
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
20
Registration Number
NCT00000707
Locations
🇺🇸

SUNY - Stony Brook, Stony Brook, New York, United States

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Phase 3
Completed
Conditions
HIV Infections
Pregnancy
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
440
Registration Number
NCT00017719
Locations
🇺🇸

Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases, Torrance, California, United States

🇺🇸

WNE Maternal Pediatric Adolescent AIDS CRS, Worcester, Massachusetts, United States

🇺🇸

Mt. Sinai Hosp. Med. Ctr. - Chicago, Womens & Childrens HIV Program, Chicago, Illinois, United States

and more 46 locations

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Phase 2
Withdrawn
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Registration Number
NCT00006339

A Study of AL721 in HIV-Infected Patients With Swollen Lymph Nodes

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
50
Registration Number
NCT00001012
Locations
🇺🇸

Beth Israel Med Ctr / Peter Krueger Clinic, New York, New York, United States

🇺🇸

Mem Sloan - Kettering Cancer Ctr, New York, New York, United States

🇺🇸

Mount Sinai Med Ctr, New York, New York, United States

and more 6 locations

Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN Alfa-2b), and Ribavirin (RBV) Treatment in Patients With Hepatitis C and HIV Coinfection

Not Applicable
Completed
Conditions
HIV Infections
Hepatitis C
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
24
Registration Number
NCT00015652
Locations
🇺🇸

Northwestern University CRS, Chicago, Illinois, United States

🇺🇸

Johns Hopkins Adult AIDS CRS, Baltimore, Maryland, United States

🇺🇸

UCLA CARE Center CRS, Los Angeles, California, United States

and more 5 locations

A Phase I Study of Methotrexate for HIV Infection

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
30
Registration Number
NCT00000834
Locations
🇺🇸

Cedars Sinai Med Ctr, Los Angeles, California, United States

🇺🇸

Univ of Kansas School of Medicine, Wichita, Kansas, United States

🇺🇸

Georgetown Univ Med Ctr, Washington, District of Columbia, United States

and more 4 locations

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
217
Registration Number
NCT00000902
Locations
🇺🇸

Connecticut Children's Med Ctr, Farmington, Connecticut, United States

🇺🇸

Cedars Sinai / UCLA Med Ctr, Los Angeles, California, United States

🇺🇸

Harbor - UCLA Med Ctr / UCLA School of Medicine, Los Angeles, California, United States

and more 59 locations

The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children

Completed
Conditions
HIV Infections
HIV Wasting Syndrome
Lipodystrophy
First Posted Date
2001-08-31
Last Posted Date
2014-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
100
Registration Number
NCT00006064
Locations
🇺🇸

Texas Children's Hosp. CRS, Houston, Texas, United States

🇺🇸

Jacobi Med. Ctr. Bronx NICHD CRS, Bronx, New York, United States

🇵🇷

University of Puerto Rico Pediatric HIV/AIDS Research Program CRS, San Juan, Puerto Rico

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Not Applicable
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
90
Registration Number
NCT00005762
Locations
🇺🇸

Stanford CRS, Palo Alto, California, United States

🇺🇸

University of Colorado Hospital CRS, Aurora, Colorado, United States

🇺🇸

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis, Indiana, United States

and more 5 locations
© Copyright 2025. All Rights Reserved by MedPath